Home / Inspections / 963057

FDA Inspection 963057 — Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

The FDA completed an inspection of Boehringer Ingelheim Pharmaceuticals, Inc. on February 26, 2016 in Ridgefield, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 26, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1281125 (VAI Thu Sep 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219707 (NAI Fri Sep 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1112627 (VAI Thu Dec 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073537 (VAI Thu Dec 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004536 (VAI Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources